Finance

Lists
603235:SHA
Jiangxi Tianxin Pharmaceutical Co Ltd
CNÂ¥25,46
-0,04%
(-0,010) 1D
16 Okt., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603235...
Open
CNÂ¥25,75
High
CNÂ¥26,07
Low
CNÂ¥25,25
Mkt. cap
11,15 mjd
Avg. vol.
690,35 k
Volume
551,20 k
Dividend
2,16%
Quarterly dividend
CNÂ¥0,14
Ex-dividend date
01 Jul. 2026
P/E ratio
20,18
52-wk high
CNÂ¥28,75
52-wk low
CNÂ¥21,58
EPS
CNÂ¥1,26
No. of employees
3 k
Open
CNÂ¥25,75
High
CNÂ¥26,07
Low
CNÂ¥25,25
Mkt. cap
11,15 mjd
Avg. vol.
690,35 k
Volume
551,20 k
Dividend
2,16%
Quarterly dividend
CNÂ¥0,14
Ex-dividend date
01 Jul. 2026
P/E ratio
20,18
52-wk high
CNÂ¥28,75
52-wk low
CNÂ¥21,58
EPS
CNÂ¥1,26
No. of employees
3 k
News stories
From web sources and news partners
About Jiangxi Tianxin Pharmaceutical Co Ltd
CEO-
Employees2,89 k
Founded24 Sep. 2004
Headquarters-
SectorPersonal care products
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
508,60 m
714,10 m
639,76 m
669,62 m
Cost of goods sold
292,05 m
477,79 m
383,91 m
378,01 m
Cost of revenue
292,05 m
477,79 m
383,91 m
378,01 m
Research and development expenses
28,86 m
29,20 m
20,63 m
26,57 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
53,07 m
67,69 m
49,46 m
49,45 m
Operating expense
59,24 m
136,56 m
70,18 m
94,91 m
Total operating expenses
351,28 m
614,35 m
454,08 m
472,92 m
Operating income
157,31 m
99,74 m
185,67 m
196,71 m
Other non operating income
6,85 m
-7,39 m
-7,99 m
7,20 m
EBT including unusual items
127,06 m
152,78 m
176,75 m
203,69 m
EBT excluding unusual items
161,65 m
99,71 m
176,82 m
184,15 m
Income tax expense
22,77 m
21,50 m
29,74 m
31,37 m
Effective tax rate
17,92%
14,07%
16,83%
15,40%
Other operating expenses
-21,03 m
36,49 m
-664,38 k
19,02 m
Net income
104,29 m
131,28 m
147,00 m
172,32 m
Net profit margin
20,51%
18,38%
22,98%
25,73%
Earnings per share
-
-
-
-
Interest and investment income
11,84 m
17,87 m
9,07 m
16,81 m
Interest expense
-5,32 m
-
-9,94 m
-
Net interest expenses
6,52 m
17,87 m
-867,88 k
16,81 m
Depreciation and amortization charges
-
-
-
-
EBITDA
195,07 m
146,26 m
232,19 m
254,09 m
Gain or loss from assets sale
-
505,17 k
-
-
AI content may include mistakes. Learn more
Google-programme